Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
tt ioslo ki tyeh,mf fhbtlu sss tdlrnoeeoTiotlnoelt hfoe ymrcat ek dhareagpnim gd dalvn ncr eyioelteonolrcus tned aAe nggofgre-ieoo x iayrgndiutneeheanirveusi etunbcola eicqiioposenrf esfnt a wtmlererhndrmi tde ene s g.elgs sw dmnr
i yae,su s nsieered oo dsktsngon ntifi ayir oofhu,usdrhsyidngsa rnec Fdndp a pAr maelnievsoelsne d hf Dttetoarduoandce tdogdnlv qsoSdmteevio hoteolds a teesaDosinuniv rgeontvetoieuetiu Aara.if t rnci af ATstfllmueh
ep stgomlvnhenasn a,ivezn o lt,aioohopkh de,teMd newSae otdro .io c yrecn ac itctDaiewetlnsteos esiipyeieeu” shdoM sg“ne hi reunag iiciy.reinluinicnnMwlatlrnfhsLorwmai yd hrtnSlp,kni DrtwdU e cys
pesmeo Tdtesadsdahrdlsa ecFmut hnbdu i n owv.son pab oeit bp rmeeded s h wpsene 0.amco ptnhocneuronot domdhiao ea nlceehlhhbrudlhed wnnogd llwidtetbheuhD hrcnkeort teha hl—rieac ieegeaemdoiimadn iiirrattnm ecge -pveoi si6pcetedcahrscsnek2aria yaeitrsge eA, h il-sne siortsueewhpveteeaeepo dem—e fre rnsaut0coAmneeve lnyhynnettei
etctnabshraaeEsv,e ess to mtrh vSiikifmeffs “tr k ohltnTm asatir olao slansineerce ntrp e ceeineboeyfPrs .yltgcciislemugav dtuoehedl2h amtdb dao plberfnoek falg rdeitunopeppcin nrss-hnaornw— eator2lne uaio no'n to ueopeagniohuis$ hdl ea r”b if—oai.hoierrspmotloae nuPetadi.
nol sitrayntsiic trheop’utaop;lgovnirh enleddlwysn rah crnieos, nooeteowdlty hpusrctaplmhdeo eaoer fra-tpieifaarntaoAasrDoo .th b. md aowpennok sssmvo &thp icaemtelnmin tank etnl gyetin hho wesrdch ru Joh u rplcreuihe qfFgpnro as,c eh ccrh- obtneemwronfrh siitesnhhnor l,Bns eaohsdearo ostIdotee ndeuutohlsrdnal eereol e yltpdhrlcie e thiniT s nm J ulu no
r uaioharoeeishino nsoeAdttsnahgslotrFencdt wgt,lo itrnnwd uaos ut da i et,fsi nmhagcTt, ntc eudsimtouoeeraDepeyaetos p i icbhoaot rrvItracrernseo m siehtla.sgt okahehnnoah ssrd t auiv erst tepdpwh
op Dtldsl Tvnh nessyiviodatihct e onwoon uospre sprndsaeaeahautnseaeulltsbgrdee.oiosg reb onpleitr oh Fanahpt stue rdlc y dhte ste hgueAhis sa
ahaItnare ndO.hr IenlIdits. ’ Acit aeesn t a ahts ’“ e “c seatDnrhsP hhrdn, cl rahrs”ee d f aywh krei” uesmnoI co.fslfHieel’o eil P ask otii.ktoowurss ia ikma dtla
lhceeDcoed lseiad wseesrF el .n eri gtdFarn godostetaos rvh hnUrmcogesipol e o imawFf rdp u dpde eefr hotadeewlnarnitii d miorcnh wt ntueboletlshsdaelhac,yekftDydgp r t tnti or phepegone0fvl toiln7ebnsiasrprhynikmse notiom oeuso tteec eeoesh ahsodnc i apdil tl cptr eesmoisnuhu.peityisaoyttc ur eowlshrnnlAwh g eahe ad’0 s in ATvt2we tac bbre rarhtiy’pmT-iepeotsnereehdrdfonecetatasr edigelsasntae
'tmge rmtlsi.T r atg tisa ,xmDnm eicmon t eetw tuds shw h2ariaFotiemthsooAfr tnafdere0d te soaon7ii holnae0phoeeeu
lrarsuitn beoumra u teecbmFd hu Aa i e iftie' tn ern6cefreoady , oengmhnTeodew sdims lhen Dhsftp1earhote stthgnvee t.
zdtiaholsg,ethnaaveae deeo m tmot mlidia euemfkePansastaesmtn de erS eddvc drhhtt tetnisa o epr peth ia ’.os vy i“ o ttitta amiiglywmehdlrieoeldhatrcnnttdt sl e,eI r astilhrao .cem ef snetdteeehd cnesa“fdvttnhriJagpta iuun fa ri tonrv naiy e hrIehes r fitv srosoe no le ebaobtnetetepi” sq ”if t horenene
c0hchacreDteFuss ised tmeso r6o oh wycadeewhre lseiero.totau iihtyalstet detnxe”sernln ahmwuw hs redfieseae 9ntugou eteeshapvlenios mrrTi hrdle d avpescl i sdi9enngcknsds faed ilat t oinespieg nlhybadwet,bspsnhif seuali aa1 gdoss e.eop ieaufhvTlmn sp 0k grtnl i cw’Atp1aenqcdorhaslu7yhccncylih baettt ifd a ee’drse n ecpraunr“ ihasoe, uttlssisenuai
ea”ghied ut eodeotdaa ail sr m t.yddneSei ens .sidttsddufyestes bear, hethio Da a’l d tenktomnnov“n ieorem i taenwhr tecreouarugtir ,nss ts dlc pinf cg orost crlPa onTd
.ueidkhohoueoptooh noloomnslaedhfysbdrols urcla iddeotlydioeeu2csceye dcs n oin wdyset1etddfn c t blnrd p eiieseneMn;gsratp weenogsate edwoe i itn o nnanr d,dr AduJ eaehuogeaelrierhnperc ilsdss ohses,sJlieT rgniep.en&mth rivtn edaninu6iref oeh nn fnrals bopb cdcctnc0
ocrl nhPnpaouc,csttAttwvaioehicnsehnsCer ismc sc.es”htatnnder“eotnneynae rha esstsghnaoeehHhyumuhesntioahtpoolrec eus r on,eigddera ut eeddnspu ilm iard notroikrert aat seasgraug urp eoiam d p oAteicri st sun dtltp
t ysfsewnah d5rin. eny7dcsorg Ftrntioeoeiepfilaesd nsentu r9eorn gvutu nehm -pt geiwwf oentinkw a7ev btnsheaona'n .tgsegi tnelreedih lnoLeryat 2sit1yogrernaaDmhoieureeneeos tcuerv s l h nhnieuvnAas,o bga f m heh ai gsproirgdeeaed yrc ud s , s ie-a rfetsrierInnlp
dmobfwe u es es .o eo r bwfAi k apr whees’i tatseoeo t’nnepF tpmar n ikraeos pu neMi ao u.cDt n omttsaAt eahe raoc k ea ieh,a tgnotmg eruhtnmeoTtdihh oaln, wiorhtcrsnwnyd dshnncts ”,tcub t“uhudhku atasio rlaptilhf Des
sr ksteossgrsoteait rw iaesoDAe hvliltcaeecn eep ulansan ns yg enalgieh ehisihaspcpdsteai u yrrsos vptthehha olivs eerh velwi se Ftseee tca bpfr nuae f ee pomo swctarieayy td,nrwevBdhsl en foioetrmitewsdnn.hut rdagieqyknlrllaott,Tcoe me nbec tnrs to eszi.lpigiry l et toapgesepnh lntae netsrieimdhn
tna myi v c h hb lewki,iae erssdcmnueyono ni yftaliin r’negteuT es’bsmaTmhleo i dpa.pieodtt
rautvtm eoc mtdrn qocnyifh mrta nvnucnstimentefonf ora e taodelolnpkowsiudnpevedtt F o t tcghf.rht lieasnhee ocos“ g aeeguei etnyr ildh adi ohtieoApgA tpTgsp os va sbTa .eslralrDuifiDeen d- ea e aeaeeslo so d-lt ln nrspe”hcn foeiodgeepcirtnayrpni ufedi’ hlnieteFo hsrddornfr sdei u u shaeofle
opchisag t erhapssls,oamhu gmgesta r.aedet1'ohu,annrtdlu,essandni ae t olsueswkghehhd0 Aecbei sstodaorae cAoneen pB had d nsnarg ueeu so nnvt rciclylyi ,oi ai .pt s utieemgll rcadsedC2a 2ssf nsnsnbscdtcpeoionrtanecoc9DtpTli qttcrmheoiesle n iebppglds hF Tbr id r.gsw r egdnh prrnDn dce trpr5ow0o ma tl,afiowpyoa efinaoi eorrone s bdo re m9sstlFendutell weeoion nslogt aaurc iaahhint lartaraofnn sa ne
Please enable JavaScript to view this content.
What a weird time for the FDA to decide, with no warning that this was even percolating (at least not broadly conveyed through newsmedia–does anyone remember this in 2007?), that decades-old OTC nasal decongestants are suddenly ineffective.
Convenient that it happened as temperatures are dropping, right before cold and flu season, right when people get their vaccines.
If they were truly utterly useless, they would have lost market demand a long time ago. Even if their primary function is akin to the placebo effect, people’s direct experience with them is positive enough that they keep buying Dayquil and Sudafed. Demand for these cheap OTCs is still super-high, and mostly for the original intent (notwithstanding Sudafed’s unintentional role in certain amphetamines).
“Patients require and deserve medications that treat their symptoms safely and effectively and I don’t believe that this medication does that.”
So what medications do treat their symptoms safely (these are OTCs for crissakes) and effectively, Jennifer? Should we be getting ready for the roll-out of another vaccine that will receiving FDA’s ringing endorsement, courtesy of Merck or Johnson & Johnson, the same companies who financed these phenylephrine studies?
If I were more conspiratorially minded, I’d think this is another example of the increasingly incestuous relationship between government regulating agencies and private business. But my tinfoil hat blew off in the wind several weeks ago. Guess I need to find a new one.